BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38778711)

  • 1. Premature mortality for patients after completely resected early adenocarcinoma of the esophagus or stomach.
    Bollschweiler E; Hölscher AH; Markar SR; Alakus H; Drebber U; Mönig SP; Plum PS
    Cancer Med; 2024 May; 13(10):e7223. PubMed ID: 38778711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia.
    Hagen JA; Peters JH; DeMeester TR
    J Thorac Cardiovasc Surg; 1993 Nov; 106(5):850-8; discussion 858-9. PubMed ID: 8231207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
    Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
    Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
    Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry.
    Alvarez-Manceñido F; Jimenez-Fonseca P; Carmona-Bayonas A; Arrazubi V; Hernandez R; Cano JM; Custodio A; Pericay Pijaume C; Aguado G; Martínez Lago N; Sánchez Cánovas M; Cacho Lavin D; Visa L; Martinez-Torron A; Arias-Martinez A; López F; Limón ML; Vidal Tocino R; Fernández Montes A; Alsina M; Pimentel P; Reguera P; Martín Carnicero A; Ramchandani A; Granja M; Azkarate A; Martín Richard M; Serra O; Hernández Pérez C; Hurtado A; Gil-Negrete A; Sauri T; Morales Del Burgo P; Gallego J
    Gastric Cancer; 2021 Jul; 24(4):926-936. PubMed ID: 33651195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved survival in resected oesophageal and gastric adenocarcinomas over a decade: the Royal Marsden experience 2001-2010.
    Fontana E; Smyth EC; Cunningham D; Rao S; Watkins D; Allum WH; Thompson J; Waddell T; Peckitt C; Chau I; Starling N
    Gastric Cancer; 2016 Oct; 19(4):1114-1124. PubMed ID: 26541768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative Treatment, Not Surgical Approach, Influences Overall Survival in Patients with Gastroesophageal Junction Tumors: A Nationwide, Population-Based Study in The Netherlands.
    Koëter M; Parry K; Verhoeven RH; Luyer MD; Ruurda JP; van Hillegersberg R; Lemmens VE; Nieuwenhuijzen GA
    Ann Surg Oncol; 2016 May; 23(5):1632-8. PubMed ID: 26727917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does chemoradiotherapy improve outcomes for surgically resected adenocarcinoma of the stomach or esophagus?
    Solomon NL; Cheung MC; Byrne MM; Zhuge Y; Franceschi D; Livingstone AS; Koniaris LG
    Ann Surg Oncol; 2010 Jan; 17(1):98-108. PubMed ID: 19777191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients.
    Rüdiger Siewert J; Feith M; Werner M; Stein HJ
    Ann Surg; 2000 Sep; 232(3):353-61. PubMed ID: 10973385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival from adenocarcinoma of the esophagus after transthoracic and transhiatal esophagectomy.
    Ovrebo KK; Lie SA; Laerum OD; Svanes K; Viste A
    World J Surg Oncol; 2012 Jun; 10():130. PubMed ID: 22747995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies.
    Hagen JA; DeMeester SR; Peters JH; Chandrasoma P; DeMeester TR
    Ann Surg; 2001 Oct; 234(4):520-30; discussion 530-1. PubMed ID: 11573045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma of the esophagogastric junction: a summary of responses to a questionnaire on adenocarcinoma of the esophagus and the esophagogastric junction in Japan.
    Nakamura T; Ide H; Eguchi R; Ota M; Shimizu S; Isono K
    Dis Esophagus; 2002; 15(3):219-25. PubMed ID: 12444994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adenocarcinoma of the esophagogastric junction: retrospective analysis of 39 patients].
    Butte JM; Becker F; Visscher A; Waugh E; Meneses M; Court I; Parada H; DE LA Fuente H
    Rev Med Chil; 2010 Jan; 138(1):53-60. PubMed ID: 20361151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcinoma.
    Zahoor H; Luketich JD; Levy RM; Awais O; Winger DG; Gibson MK; Nason KS
    J Thorac Cardiovasc Surg; 2015 Feb; 149(2):538-47. PubMed ID: 25454907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited resection for early adenocarcinoma in Barrett's esophagus.
    Stein HJ; Feith M; Mueller J; Werner M; Siewert JR
    Ann Surg; 2000 Dec; 232(6):733-42. PubMed ID: 11088068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
    Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
    Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.
    Omloo JM; Lagarde SM; Hulscher JB; Reitsma JB; Fockens P; van Dekken H; Ten Kate FJ; Obertop H; Tilanus HW; van Lanschot JJ
    Ann Surg; 2007 Dec; 246(6):992-1000; discussion 1000-1. PubMed ID: 18043101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification, diagnosis and surgical treatment of carcinomas of the gastroesophageal junction.
    Mönig SP; Schröder W; Beckurts KT; Hölscher AH
    Hepatogastroenterology; 2001; 48(41):1231-7. PubMed ID: 11677937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical transhiatal esophagectomy with two-field lymphadenectomy and endodissection for distal esophageal adenocarcinoma.
    Bumm R; Feussner H; Bartels H; Stein H; Dittler HJ; Höfler H; Siewert JR
    World J Surg; 1997 Oct; 21(8):822-31. PubMed ID: 9327673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.